Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The aim of our study was to evaluate the Greek version of the transfusion-dependent quality of life (TranQol) questionnaire and report our experience of using this novel disease-specific quality of life (QoL) measure in patients with transfusion-dependent thalassemia (TDT). The TranQol and SF-36v2 questionnaires were administered to 94 adult TDT patients with a mean age of 32.1 years (SD = 7, range = 19-58), recruited from the Adult Thalassemia Unit of Hippokration General Hospital of Thessaloniki, Greece. The TranQol was evaluated in terms of construct validity, reliability, and responsiveness. There was a moderately strong correlation between the TranQol summary and both the SF-36v2 physical and mental component summaries (r = 0.4, p 

Original publication

DOI

10.1007/s00277-017-3122-7

Type

Journal article

Journal

Ann Hematol

Publication Date

11/2017

Volume

96

Pages

1937 - 1944

Keywords

Beta-thalassemia major, Patient-reported outcome measures, Quality of life, Transfusion-dependent thalassemia, Adult, Blood Transfusion, Cross-Sectional Studies, Female, Greece, Humans, Iron Chelating Agents, Longitudinal Studies, Male, Middle Aged, Quality of Life, Reproducibility of Results, Surveys and Questionnaires, beta-Thalassemia